0001719289-20-000002.txt : 20200218 0001719289-20-000002.hdr.sgml : 20200218 20200218131940 ACCESSION NUMBER: 0001719289-20-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200218 DATE AS OF CHANGE: 20200218 EFFECTIVENESS DATE: 20200218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PharmID, Inc. CENTRAL INDEX KEY: 0001719289 IRS NUMBER: 821123994 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-317795 FILM NUMBER: 20624503 BUSINESS ADDRESS: STREET 1: 2157 N. NORTHLAKE WAY #240 CITY: SEATTLE STATE: WA ZIP: 98103 BUSINESS PHONE: 425-830-1704 MAIL ADDRESS: STREET 1: 2157 N. NORTHLAKE WAY #240 CITY: SEATTLE STATE: WA ZIP: 98103 D/A 1 primary_doc.xml X0708 D/A LIVE 0001719289 PharmID, Inc. 2157 N. NORTHLAKE WAY #240 SEATTLE WA WASHINGTON 98103 206-992-3589 DELAWARE None None Corporation true 2017 Brian Marquardt 2157 N. Northlake Way, #240 Seattle WA WASHINGTON 98103 Executive Officer Director J. Scott Van Vuren 2157 N. Northlake Way, #240 Seattle WA WASHINGTON 98103 Executive Officer Director Tom Pierson 2157 N. Northlake Way, #240 Seattle WA WASHINGTON 98103 Executive Officer Christopher Swasand 2157 N. Northlake Way, #240 Seattle WA WASHINGTON 98103 Director Other Health Care Decline to Disclose 06b true 0001719289-18-000001 2018-07-13 true true false 0 4999996 4999996 0 false 13 0 0 0 false PharmID, Inc. Thomas Michael Pierson Thomas Michael Pierson Chief Financial Officer 2020-02-18